![Insights from 2023 ASCO® Annual Meeting](http://media.vumedi.com/thumbs/channel_logo/2023/5/a2df459d-f523-49c6-86db-fbc880f4b695.png.200x0_q85.png)
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Phase 3 STELLAR-303 Study - XL092 in Combination With Atezo vs. Regorafenib in Previously Treated mCRC"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
J. Randolph Hecht
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
J. Randolph Hecht
47 views
July 2, 2023
Comments 0
Login to view comments.
Click here to Login
GI